Thermo Fisher Scientific Inc (N:TMO)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 168 Third Avenue
WALTHAM MA 02451
Tel: 1-781-6221111
Website: https://www.thermofisher.com
IR: See website
<
Key People
Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Stephen Williamson
Chief Financial Officer, Senior Vice President
Michel Lagarde
Chief Operating Officer, Executive Vice President
Gianluca Pettiti
Executive Vice President
Michael A. Boxer
Senior Vice President, General Counsel
Joseph Holmes
Chief Accounting Officer, Vice President
Business Overview
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.
Financial Overview
For the fiscal year ended 31 December 2023, Thermo Fisher Scientific Inc revenues decreased 5% to $42.86B. Net income decreased 14% to $6B. Revenues reflect Life Sciences Solutions segment decrease of 26% to $9.98B, Speciality Diagnostics segment decrease of 8% to $4.41B, North America segment decrease of 7% to $22.76B, Asia Pacific segment decrease of 3% to $7.87B, Europe segment decrease of less than 1% to $10.74B.
Employees: 122,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $247,758M as of Dec 31, 2023
Annual revenue (TTM): $42,857M as of Dec 31, 2023
EBITDA (TTM): $10,757M as of Dec 31, 2023
Net annual income (TTM): $5,995M as of Dec 31, 2023
Free cash flow (TTM): $6,404M as of Dec 31, 2023
Net Debt Last Fiscal Year: $26,837M as of Dec 31, 2023
Shares outstanding: 381,312,268 as of Feb 3, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.